Literature DB >> 21225744

Anti-EMMPRIN treatment of HNSCC in an ex vivo model.

Nichole Dean1, Emily Helman, Joszi Aldridge, William Carroll, Scott Magnuson, Eben Rosenthal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21225744     DOI： 10.1002/lary.21610

Source DB:  PubMed          Journal:  Laryngoscope        ISSN： 0023-852X            Impact factor:   3.325


× No keyword cloud information.
  3 in total

1.  Secreted cyclophilin A mediates G1/S phase transition of cholangiocarcinoma cells via CD147/ERK1/2 pathway.

Authors:  Sumalee Obchoei; Kanlayanee Sawanyawisuth; Chaisiri Wongkham; Watchara Kasinrerk; Qizhi Yao; Changyi Chen; Sopit Wongkham
Journal:  Tumour Biol       Date:  2014-10-10

2.  A novel anti-EMMPRIN function-blocking antibody reduces T cell proliferation and neurotoxicity: relevance to multiple sclerosis.

Authors:  Smriti M Agrawal; Claudia Silva; Janet Wang; Jade Pui-Wai Tong; V Wee Yong
Journal:  J Neuroinflammation       Date:  2012-04-05       Impact factor: 8.322

Review 3.  Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis.

Authors:  Cory D Bovenzi; James Hamilton; Patrick Tassone; Jennifer Johnson; David M Cognetti; Adam Luginbuhl; William M Keane; Tingting Zhan; Madalina Tuluc; Voichita Bar-Ad; Ubaldo Martinez-Outschoorn; Joseph M Curry
Journal:  Biomed Res Int       Date:  2015-12-08       Impact factor: 3.411
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.